image
Healthcare - Medical - Devices - NASDAQ - US
$ 2.5
-0.738 %
$ 6.29 M
Market Cap
-0.18
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one SINT stock under the worst case scenario is HIDDEN Compared to the current market price of 2.5 USD, Sintx Technologies, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one SINT stock under the base case scenario is HIDDEN Compared to the current market price of 2.5 USD, Sintx Technologies, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one SINT stock under the best case scenario is HIDDEN Compared to the current market price of 2.5 USD, Sintx Technologies, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SINT

image
$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.0$1.5$1.515 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
2.89 M REVENUE
9.90%
-14 M OPERATING INCOME
-5.16%
-11 M NET INCOME
-33.48%
-8.64 M OPERATING CASH FLOW
38.77%
-194 K INVESTING CASH FLOW
61.28%
9.09 M FINANCING CASH FLOW
-22.35%
192 K REVENUE
-75.97%
-1.73 M OPERATING INCOME
72.97%
-1.7 M NET INCOME
72.83%
-1.12 M OPERATING CASH FLOW
56.26%
10 K INVESTING CASH FLOW
132.26%
-102 K FINANCING CASH FLOW
-3.57%
Balance Sheet Sintx Technologies, Inc.
image
Current Assets 4.77 M
Cash & Short-Term Investments 3.6 M
Receivables 196 K
Other Current Assets 977 K
Non-Current Assets 4.64 M
Long-Term Investments 0
PP&E 4.08 M
Other Non-Current Assets 561 K
38.22 %10.38 %43.35 %5.96 %Total Assets$9.4m
Current Liabilities 1.98 M
Accounts Payable 299 K
Short-Term Debt 488 K
Other Current Liabilities 1.2 M
Non-Current Liabilities 3.54 M
Long-Term Debt 0
Other Non-Current Liabilities 3.54 M
5.42 %8.84 %21.65 %64.09 %Total Liabilities$5.5m
EFFICIENCY
Earnings Waterfall Sintx Technologies, Inc.
image
Revenue 2.89 M
Cost Of Revenue 811 K
Gross Profit 2.08 M
Operating Expenses 15.3 M
Operating Income -14 M
Other Expenses -3.02 M
Net Income -11 M
4m4m2m2m00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)(12m)(12m)(14m)(14m)(16m)(16m)3m(811k)2m(15m)(14m)3m(11m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
71.91% GROSS MARGIN
71.91%
-486.56% OPERATING MARGIN
-486.56%
-381.85% NET MARGIN
-381.85%
-283.10% ROE
-283.10%
-117.11% ROA
-117.11%
-177.38% ROIC
-177.38%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Sintx Technologies, Inc.
image
00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)(12m)(12m)(14m)(14m)(16m)(16m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -11 M
Depreciation & Amortization 1.38 M
Capital Expenditures -690 K
Stock-Based Compensation 82 K
Change in Working Capital 0
Others 916 K
Free Cash Flow -9.33 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Sintx Technologies, Inc.
image
SINT has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Sintx Technologies, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
52.9 K USD 2
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules Salt Lake City, Utah, Feb. 26, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc., (“SINTX” or the “Company”) (Nasdaq: SINT), a leader in advanced ceramics for medical applications, today announced that it has, pursuant to a securities purchase agreement with institutional and accredited investors dated February 20, 2025, issued and sold 1,449,287 shares of common stock (or pre-funded warrants in lieu therof) at a purchase price of $3.45 per share (or pre-funded warrant in lieu thereof) in a private placement priced at-the-market under Nasdaq rules. In addition, the Company issued to the investors in the offering unregistered warrants (the “warrants”) to purchase up to an aggregate of 1,449,287 shares of common stock. globenewswire.com - 2 months ago
SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market Strategic Transaction Enhances Financial Flexibility and Supports Growth in Healthcare Innovations Salt Lake City, UT, Feb. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), a leader in advanced ceramics for medical applications, today announced the sale of its wholly-owned subsidiary, Technology Assessment and Transfer (TA&T), to Tethon Corporation DBA Tethon 3D (Tethon). This transaction marks a significant step in SINTX's ongoing transformation, allowing the Company to sharpen its focus on high-growth opportunities in the medical device sector while improving its financial position and operational efficiency. globenewswire.com - 2 months ago
SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial Salt Lake City, Utah, Feb. 19, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) an advanced ceramics company specializing in the development and commercialization of materials, components, and technologies for medical and technical applications, today announced the issuance of U.S. Patent No. 12,239,761 by the United States Patent and Trademark Office (USPTO). globenewswire.com - 2 months ago
SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announces the signing of a Joint Development Agreement (JDA) with NED Medical Inc., an innovative developer of oncology embolization therapy technologies. This collaboration aims to accelerate the development of advanced ceramic-based microspheres, a groundbreaking advancement in radiotherapeutic applications. globenewswire.com - 5 months ago
SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, is pleased to announce the appointment of Gregg R. Honigblum as Chief Strategy Officer (CSO). globenewswire.com - 5 months ago
SINTX Technologies Announces Stock Repurchase Program Salt Lake City, UT , Nov. 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, today announced that its Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company's outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares. The repurchases will be conducted based on market conditions and other factors, reflecting SINTX's confidence in its strategic direction and commitment to enhancing shareholder value. globenewswire.com - 6 months ago
SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announced today a positive update on its recent strategic initiatives and financial performance, showcasing the Company's commitment to realigning its resources and achieving long-term growth. globenewswire.com - 6 months ago
SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T Salt Lake City, Utah, Oct. 01, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) an advanced materials company specializing in ceramics for biomedical, aerospace, and industrial applications, is pleased to announce two key executive promotions. globenewswire.com - 7 months ago
Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing” Salt Lake City, Utah, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leader in advanced ceramics, and Prodways, a global specialist in 3D printing solutions, are excited to announce their jointly sponsored webinar: “Innovations in Ceramic Manufacturing: The Role of 3D Printing.” This live webinar, organized in partnership with TCT Magazine, will take place on September 24th at 9:00 AM EDT/3:00 PM CEST. globenewswire.com - 7 months ago
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial Salt Lake City, Utah, Sept. 09, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leading innovator in ceramic manufacturing, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 17/634,141 entitled "Methods of Surface Functionalization of Zirconia-Toughed Alumina with Silicon Nitride Ceramic.” This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed. globenewswire.com - 8 months ago
SINTX Technologies to Explore Strategic Opportunities Salt Lake City, Utah., June 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) today announced that its Board of Directors has initiated a process to explore potential strategic options for the Company. globenewswire.com - 11 months ago
SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement Salt Lake City, Utah., June 12, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (SINTX) (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, today announced that on June 11, 2024, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has evidenced compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Accordingly, the previously announced listing matter has been closed. globenewswire.com - 11 months ago
8. Profile Summary

Sintx Technologies, Inc. SINT

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 6.29 M
Dividend Yield 0.00%
Description Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Contact 1885 West 2100 South, Salt Lake City, UT, 84119 https://www.sintx.com
IPO Date Feb. 13, 2014
Employees 20
Officers Mr. Eric K. Olson President, Chief Executive Officer & Chairman of the Board Mr. Gregg Richard Honigblum Chief Investment Officer & Director Dr. Ryan Bock Ph.D. Chief Technology Officer